Company intelligence / Profile preview

Lumonus

Ownership: Private
Development stage: Commercial

Overview

Lumonus is an active health technology company focused on transforming cancer care by empowering oncology care teams with AI-powered software solutions and value-added services. Their offerings include oncology workflow software, remote dosimetry, physics commissioning, and comprehensive physics services designed to improve quality, efficiency, and experience in delivering cancer treatment[1][2]. The company's mission centers on making quality cancer care accessible globally by supporting providers with innovative digital tools.

Therapeutic areas: Oncology
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Lumonus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lumonus.

Explore the full profile